The 2020 ICCTF meeting will be held immediately before the 48th annual INS meeting (https://www.the-ins.org) in Denver, Colorado. 

The dates of the ICCTF meeting are February 3 and 4, 2020, INS is February 5-8, 2020. 

The location of both meetings: Hyatt Regency Denver at Colorado Convention Center. 650 15th Street, Denver, Colorado, United States, 80202

Meet our ICCTF Keynote Speakers:

  • Judy Campisi, PhD (California, The Buck Institute): biology of aging, inflammation and cellular senescence

  • Steve Cole, PhD (California, UCLA): stress, cognitive function, and social genomics

  • Kevin Duff, PhD (Utah, U Utah): novel longitudinal assessment methods

  • Roy P.C. Kessels, PhD (The Netherlands, Radboud University): cognitive rehabilitation

  • Lars Nyberg, PhD (Sweden, Umeå University): brain imaging and memory

Capture.JPG


  • Judy Campisi, PhD (California, The Buck Institute): biology of aging, inflammation and cellular senescence

    Professor Judy Campisi is a biochemist and cell biologist. She is Professor of Biogerontology at the Buck Institute for Research on Aging. Her research focuses on cellular senescence, aging and cancer. After joining the Lawrence Berkeley National Laboratory as a senior scientist in 1991, she started the Campisi laboratory at the Buck Institute in 2001.

    Her research focuses on the role of cellular senescence and its relationship with aging. Senescent cells are important in preventing early-life cancer, but, ironically, also contribute to aging, cause inflammation and drive the progression of cancer with aging. The Campisi laboratory uses genetic and pharmacological manipulations of human and mouse cell tissues to understand how cell states, with an emphasis on cellular senescence, drive cancer and other age-related disease. They further examine strategies to modulate or prevent the effects.

    Professor Campisi is a member of the National Academy of Sciences and a fellow of the American Association for the Advancement of Science. She has received numerous awards for her research on aging, among which are two MERIT awards from the National Institute on Aging and awards from the AlliedSignal Corporation, Gerontological Society of America, and American Federation for Aging Research, and the first international prize in Natural Sciences and Medicine from the Olav Thon Foundation.

  • Steve Cole, PhD (California, UCLA): stress, cognitive function, and social genomics

    Steve Cole is Professor of Medicine in the Division of Hematology-Oncology,  Psychiatry and Biobehavioral Science at the UCLA School of Medicine. As pioneer in the field of human social genomics Professor Cole introduced the use of functional genomics in social and behavioral research.

    His research addresses molecular pathways by which social environments influence gene expression of viral, cancer, and immune cell genomes. He has amongst others mapped pathways via which social factors enhance replication of viruses, alter expression of key immune response genes, and up-regulate expression of pro-metastatic genes in breast and ovarian cancer cells. In addition, he has developed bioinformatics tools to facilitate this field of research, including Transcript Origin Analysis (to identify the cellular sources of differentially expressed genes), the Transcription Element Listening System (TELiS; to identify transcription factors mediating differential gene expression), and the GEscan algorithm (to identify genetic polymorphisms that affect transcriptional responses to environmental stimuli). As director of the UCLA Social Genomics Core Laboratory, he supports similar research programs world-wide. He provides consulting support on social regulation of gene expression to the Institute of Medicine, the National Cancer Institute, the National Institute on Aging, the Santa Fe Institute for Complex Systems, and the MacArthur Foundation, among others.

  • Kevin Duff, PhD (Utah, U Utah): novel longitudinal assessment methods

    Professor Kevin Duff’s research focuses on clinical neuropsychology, aging and dementia. After obtaining his PhD in Clinical Psychology from the State University of New York at Albany, he first joined the Psychiatry Department at the University of Iowa but later moved to the University of Utah where he was awarded Professor of Neurology with Tenure in 2016.

    His research interests include longitudinal cognitive assessment, practice effects, and cognitive decline in normal aging, MCI, and dementia. Specifically, he discovered how practice effects can predict cognitive decline in MCI, which can potentially serve as a marker of early Alzheimer’s disease.  Currently, he investigates whether practice effects could predict who benefits most from certain interventions (i.e., personalized medicine) and if practice effects are related to other biomarkers of Alzheimer’s disease (e.g., amyloid deposition, hippocampal atrophy, APOE e4).

    He has specialized in neuropsychology for over a decade, became board-certified in Clinical Neuropsychology by the American Board of Professional Psychology in 2011, and works as a neuropsychologist for the Center for Alzheimer’s Care, Imaging and Research. Professor Duff is a member of the American Psychological Association, International Neuropsychological Society, and National Academy of Neuropsychology, amongst others. He has published over 130 research articles in international peer-reviewed scientific journals. In 2009, he received the Nelson Butters Award for publishing the most influential paper of the year. His work on practice effects in MCI and dementia has been funded by the NIH since 2005.

  • Roy P.C. Kessels, PhD (The Netherlands, Radboud University): cognitive rehabilitation

    Roy Kessels is Professor of Neuropsychology at the Radboud University since 2008 and head of the Department of Neuropsychology and Rehabilitation Psychology. He is principal investigator at the Donders Centre for Cognition and the Donders Institute for Brain, Cognition and Behaviour. In his multidisciplinary research he investigates memory function with a focus on implicit learning, working memory and episodic memory by combining various methods of neuroimaging and experimental (neuro)psychology. He also collaborates with clinical disciplines such as neurology, geriatrics, psychiatry and internal medicine to examine memory deficits in brain diseases such as MCI, dementia, stroke and Korsakoff’s syndrome.

    Aside from his scientific career Professor Kessels also works as a clinical neuropsychologist at the department of Medical Psychology of the Radboud University Medical Center. His involvement in various research projects concerning neuropsychological assessment and cognitive rehabilitation has contributed significantly to the clinical field. Currently, he is involved among others in the Advanced Neuropsychological Diagnostics Infrastructure (ANDI) Consortium and the JPND Program NeuroExercise. He further is a member of various advisory boards, including the Federation of European Societies of Neuropsychology, the Dutch Korsakoff Knowledge Centre, and the PaON Foundation.

  • Lars Nyberg, PhD (Sweden, Umeå University): brain imaging and memory

    Lars Nyberg is a Professor of Neuroscience at the departments of Radiation Sciences and Integrative Medical Biology (IMB) of Umeå University. He obtained his PhD in 1993 after which he served as a post-doctoral fellow at the Rotman Research Institute, Toronto, Canada.

    He is the director of the Umeå Center for Functional Brain Imaging (UFBI) and has been active in the field of functional neuroimaging (PET & fMRI) of memory for decades. His multidisciplinary research combines neuroscience, cognitive psychology and genetics. He is the principal investigator of the Betula study, a longitudinal study on aging, memory and dementia. He aims to identify genetic, brain and life-style predictors of heterogeneity in cognitive-aging profiles by studying how memory functions change during adult life.

    Professor Nyberg was elected a member of the Royal Swedish Academy of Sciences in 2008 and received several prizes among which is the Gustafsson Prize in medicine in 2007. His expertise on neuroimaging and the study of brain function led him to participate in the EU’s major research initiative the Human Brain Project, and currently in the Eu2020 project Lifebrain

ABSTRACT SUBMISSION - ICCTF AND INS REGISTRATION - ACCOMMODATION

ICCTF and INS registration is open at: https://www.the-ins.org/ins-events/

Please note that EARLY registration is open until November 22, 2019

Abstract submission is closed. Notification of ICCTF abstract acceptance is expected early November 2019.

 Fees for the ICCTF meeting are depicted in the table below. The fee for the Networking event is 75$

ICCTF Networking Event – Denver Style! Monday, February 3rd, 2020

Join us for an evening of local microbrews, wine, and catered dinner in a convivial setting with beautiful views of the mountain and city skyline at the Great Divide Brewing Company.  Group transportation is included.

*The networking event is generously supported by the Department of Neurosurgery at the University of Colorado School of Medicine

Fees for registration to both ICCTF and INS are depicted in the table below.

Picture1.png

ACCOMMODATION

ICCTF attendees (regardless of attending INS as well) can make us of the DISCOUNTED GUEST ROOM rates at the conference hotel: the Hyatt Regency Denver at Colorado Convention Center

Use this link to make your hotel reservation: https://www.the-ins.org/meetings/denver2020/accommodations/

To receive the discounted room rate, book your room by the cutoff date January 8, 2020 at midnight (EST).

01_exterior-night-view_rs-1.jpg